Rockwell Medical (RMTI) Short term Debt (2013 - 2026)

Rockwell Medical's Short term Debt history runs 11 years deep, the most recent figure standing at $707000.0 for Q1 2026.

• Quarterly Short term Debt fell 70.98% year-over-year to $707000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $707000.0 (down 70.98% YoY) and the FY2025 annual result came in at $1.0 million, down 57.82% from the prior year.
• Short term Debt was $707000.0 for Q1 2026 at Rockwell Medical, down from $1.0 million in the prior quarter.
• Across five years, Short term Debt topped out at $6.6 million in Q1 2022 and bottomed at $707000.0 in Q1 2026.
• A 5-year average of $2.9 million and a median of $2.5 million in 2023 frame the typical range for Short term Debt.
• Peak annual rise in Short term Debt reached 3777.78% in 2022, while the deepest fall reached 77.9% in 2022.
• Rockwell Medical's Short term Debt stood at $1.6 million in 2022, then soared by 53.28% to $2.5 million in 2023, then declined by 5.16% to $2.4 million in 2024, then sank by 57.82% to $1.0 million in 2025, then retreated by 29.3% to $707000.0 in 2026.
• Business Quant data shows RMTI's Short term Debt at $707000.0 in Q1 2026, $1.0 million in Q4 2025, and $1.8 million in Q3 2025.